Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Canadian Imperial Bank of Commerce
CM
|
+$637M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$608M |
| 3 |
JPMorgan Chase
JPM
|
+$563M |
| 4 |
Canadian Natural Resources
CNQ
|
+$502M |
| 5 |
Air Products & Chemicals
APD
|
+$389M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$6.76B |
| 2 |
NVIDIA
NVDA
|
+$984M |
| 3 |
Morgan Stanley
MS
|
+$979M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$878M |
| 5 |
Microsoft
MSFT
|
+$871M |
Sector Composition
| 1 | Financials | 19.76% |
| 2 | Technology | 16.78% |
| 3 | Industrials | 8.53% |
| 4 | Healthcare | 7.7% |
| 5 | Consumer Discretionary | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5901
Orchestra BioMed
OBIO
$139M
| $4K | ﹤0.01% |
664
-4,595
| -87% | -$27.7K |
|
5902
Synchronoss Technologies
SNCR
$66.9M
| $4K | ﹤0.01% |
500
+259
| +107% | +$2.07K |
|
5903
Aclaris Therapeutics
ACRS
$211M
| $4K | ﹤0.01% |
2,965
-20,423
| -87% | -$27.6K |
|
|
AEVA
5904
Aeva Technologies
AEVA
$903M
| $4K | ﹤0.01% |
1,229
-3,893
| -76% | -$12.7K |
|
|
AKYA
5905
DELISTED
Akoya BioSciences
AKYA
| $4K | ﹤0.01% |
1,041
-7,022
| -87% | -$27K |
|
5906
AlTi Global
ALTI
$388M
| $4K | ﹤0.01% |
708
-6,689
| -90% | -$37.8K |
|
5907
Aemetis
AMTX
$137M
| $4K | ﹤0.01% |
585
-571
| -49% | -$3.9K |
|
5908
Asure Software
ASUR
$215M
| $4K | ﹤0.01% |
512
-5,835
| -92% | -$45.6K |
|
5909
Aterian
ATER
$9.73M
| $4K | ﹤0.01% |
1,327
+1,238
| +1,391% | +$3.73K |
|
5910
BARK
BARK
$150M
| $4K | ﹤0.01% |
3,048
-39,594
| -93% | -$52K |
|
5911
BioAtla
BCAB
$45.5M
| $4K | ﹤0.01% |
1,407
-11,690
| -89% | -$33.2K |
|
5912
BioVie
BIVI
$14.1M
| $4K | ﹤0.01% |
81
-31
| -28% | -$1.53K |
|
5913
BlackSky Technology
BKSY
$684M
| $4K | ﹤0.01% |
347
-4,424
| -93% | -$51K |
|
5914
SonicShares Global Shipping ETF
BOAT
$46.5M
| $4K | ﹤0.01% |
141
+137
| +3,425% | +$3.89K |
|
5915
BioXcel Therapeutics
BTAI
$49.8M
| $4K | ﹤0.01% |
90
-327
| -78% | -$14.5K |
|
5916
Compass Therapeutics
CMPX
$613M
| $4K | ﹤0.01% |
2,070
-27,018
| -93% | -$52.2K |
|
5917
Curis
CRIS
$22.7M
| $4K | ﹤0.01% |
422
+257
| +156% | +$2.44K |
|
5918
Alpha Tau Medical
DRTS
$324M
| $4K | ﹤0.01% |
1,500
| – | – |
|
5919
eGain
EGAN
$220M
| $4K | ﹤0.01% |
611
-5,882
| -91% | -$38.5K |
|
5920
Erasca
ERAS
$443M
| $4K | ﹤0.01% |
1,894
-23,423
| -93% | -$49.5K |
|
|
HYPD
5921
Hyperion DeFi, Inc. Common Stock
HYPD
$85.3M
| $4K | ﹤0.01% |
46
-108
| -70% | -$9.39K |
|
5922
First Trust Latin America AlphaDEX Fund
FLN
$17M
| $4K | ﹤0.01% |
200
| – | – |
|
5923
Great Elm Capital Corp
GECC
$147M
| $4K | ﹤0.01% |
355
| – | – |
|
5924
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$95.9M
| $4K | ﹤0.01% |
+78
| New | +$4K |
|
5925
Gossamer Bio
GOSS
$787M
| $4K | ﹤0.01% |
3,150
-66
| -2% | -$84 |
|